Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sher

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Archives of Plastic Surgery|September 25, 2019
Utility of a modified components separation for abdominal wall reconstruction in the liver and kidney transplant populationCara K Black, Elizabeth G Zolper, Elliot T Walters, et al.
Lung|April 7, 2021
Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist GefapixantAlyn H Morice, Surinder S Birring, Jaclyn A Smith, et al.
Lung|June 1, 2023
Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI StudyPeter V Dicpinigaitis, Alyn H Morice, Jaclyn A Smith, et al.
Journal of Medicinal Chemistry|September 13, 1996
2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleusJ W Clader, D A Burnett, M A Caplen, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|January 26, 2020
Long term outcomes of abdominal wall reconstruction using open component separation and biologic mesh in the liver, kidney, and small bowel transplant populationE G Zolper, C K Black, C Devulapalli, et al.
The Lancet. Respiratory Medicine|February 29, 2020
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trialJaclyn A Smith, Michael M Kitt, Alyn H Morice, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|October 5, 2020
Increased Incidence of Acute Pulmonary Embolism in Emergency Department Patients During the COVID-19 PandemicJennifer M Watchmaker, Daryl T Goldman, Jun Yeop Lee, et al.
British Medical Journal|November 29, 1975
Outbreake of Marburg virus disease in JohannesburgJ S Gear, G A Cassel, A J Gear, et al.
Nature|February 5, 2025
Synthetic lethality of mRNA quality control complexes in cancerVivian Prindle, Adam E Richardson, Kimberly R Sher, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 28, 2020
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On StudyBrian P Vickery, Andrea Vereda, Caroline Nilsson, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Archives of Plastic Surgery|September 25, 2019
Utility of a modified components separation for abdominal wall reconstruction in the liver and kidney transplant populationCara K Black, Elizabeth G Zolper, Elliot T Walters, et al.
Lung|April 7, 2021
Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist GefapixantAlyn H Morice, Surinder S Birring, Jaclyn A Smith, et al.
Lung|June 1, 2023
Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI StudyPeter V Dicpinigaitis, Alyn H Morice, Jaclyn A Smith, et al.
Journal of Medicinal Chemistry|September 13, 1996
2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleusJ W Clader, D A Burnett, M A Caplen, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|January 26, 2020
Long term outcomes of abdominal wall reconstruction using open component separation and biologic mesh in the liver, kidney, and small bowel transplant populationE G Zolper, C K Black, C Devulapalli, et al.
The Lancet. Respiratory Medicine|February 29, 2020
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trialJaclyn A Smith, Michael M Kitt, Alyn H Morice, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|October 5, 2020
Increased Incidence of Acute Pulmonary Embolism in Emergency Department Patients During the COVID-19 PandemicJennifer M Watchmaker, Daryl T Goldman, Jun Yeop Lee, et al.
British Medical Journal|November 29, 1975
Outbreake of Marburg virus disease in JohannesburgJ S Gear, G A Cassel, A J Gear, et al.
Nature|February 5, 2025
Synthetic lethality of mRNA quality control complexes in cancerVivian Prindle, Adam E Richardson, Kimberly R Sher, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 28, 2020
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On StudyBrian P Vickery, Andrea Vereda, Caroline Nilsson, et al.
Pageof 12